Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026)
Citius Oncology (CTOR) posted quarterly Interest & Investment Income of $43721.0 for Q1 2026, up 54.56% quarter-over-quarter from $28288.0 in Q4 2025.
Citius Oncology (CTOR) Interest & Investment Income (2025 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Interest & Investment Income for 2 consecutive years, with $43721.0 the latest figure, recorded in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Citius Oncology | 82.91 Mn | 82.91 Mn | 1.00 Mn | 96,848.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43,721.00 |
| Dec 31, 2025 | 28,288.00 |